Factory Supply Best Price Indole Butyric Acid Powder

Share on (60810707571):


Price:RUB 7,581.80 - RUB 11,372.70

Quantity:


Product Overview

Description

Factory Supply Best Price Indole Butyric Acid Powder

 

.jpg

1. Basic Information.jpg

Product Name

Indole Butyric Acid Powder

Specification

 99%

Cas No

 700-06-1

Einecs No

 211-836-2

Molecular formula

 C9H9NO

Molecular weight

 147.18 

3. Product description.jpg

Indole Butyric Acid Powder (C9H9NO) is produced by the breakdown of the glucosinolate glucobrassicin, which can be found at relatively high levels in cruciferous vegetables such as broccoli, cabbage, cauliflower, brussels sprouts, collard greens and kale. indole-3-carbinol is also available in a dietary supplement. indole-3-carbinol is the subject of on-going Biomedical research into its possible anticarcinogenic, antioxidant, and antiatherogenic effects. 


Indole Butyric Acid Powder can shift estrogen metabolism towards less estrogenic metabolites. indole-3-carbinol has an effect on human papilloma virus infected cells in both pediatrics and adult patients.

2. Sample Play.jpg


4.Test Report.jpgIndole-3-carbinol.jpg

 

6. Function.jpg

1. Indole 3 Carbinol anticarcinogenic;
2. Indole 3 Carbinol anti-atherogenic. 
3. Indole 3 Carbinol can anti-oxidant;
4. Indole 3 Carbinol prevention and treatment of cancer;
5.  Indole 3 Carbinol may have an effect on human papillomavirus  infected cells in both pediatrics and adult patients;

5. Application.jpg

 

The primary use of dextromethorphan is as a cough suppressant, for the temporary relief of cough caused by minor throat and bronchial irritation (such as commonly accompanies the flu and common cold), as well as those resulting from inhaled particle irritants.

Pseudobulbar affect and other neuropsychiatric disorders.

In 2010,The combination is also under investigation for the treatment of a variety of other neurological and neuropsychiatric conditions, such as agitation  associated with Alzheimer's disease andmajor depressive disorder.Dextromethorphan is the actual therapeutic agent in the combination; quinidinemerely serves to inhibit the enzymatic degradation of dextromethorphan and thereby increase its circulating concentrations via inhibition of CYP2D6.

7.jpg16.jpg

1.jpg1_26.jpg

0.1887 s.